Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Ovarian Neoplasms 2Fallopian Tube Neoplasms 2Breast Neoplasms 2Sarcoma, Kaposi 1Carcinoma, Ovarian Epithelial 1Acquired Immunodeficiency Syndrome 1AIDS-related Kaposi sarcoma 1

Interventions

Polymerase Chain Reaction 2Paclitaxel 2nirogacestat 1liposomal doxorubicin 1emvododstat 1Valproic Acid 1Sirolimus 1Semaxinib 1Saquinavir 1Ritonavir 1Palliative Care 1Nutritional Support 1Nelfinavir 1Indinavir 1Immunohistochemistry 1Imatinib Mesylate 1Histological Techniques 1Gene Expression Profiling 1Daunorubicin 1Celecoxib 1Biopsy 1Analgesia 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × AIDS-related Kaposi sarcoma × liposomal doxorubicin × Clear all
NCT05411237 2026-01-23

Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma

AIDS Malignancy Consortium

Phase 3 Not yet recruiting
130 enrolled
Sarcoma

AIDS-related Kaposi sarcoma, Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡